Reuters logo
BRIEF-Proteon Therapeutics announces data from trial of investigational vonapanitase in patients with CKD
December 13, 2016 / 12:22 PM / 10 months ago

BRIEF-Proteon Therapeutics announces data from trial of investigational vonapanitase in patients with CKD

Dec 13 (Reuters) - Proteon Therapeutics Inc

* Secondary and tertiary endpoint data and enrollment in second phase 3 ongoing

* Trial did not meet primary efficacy endpoint

* Announces top-line data from phase 3 patency-1 clinical trial of investigational vonapanitase in patients with CKD Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below